What is the long-term trend for AbCellera Biologics Inc.'s unrealized gain on equity investment?

Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s unrealized gain on equity investment has grown at a -66.7% compound annual growth rate (CAGR), from $1.8M to $200K.

AbCellera Biologics Inc. ABCL Unrealized gain on equity investment

Unrealized gain on equity investment at other companies

Atmos EnergyATO

$43.5K-95.1%

WSFS FinancialWSFS

$1.76M+41.2%

CaterpillarCAT

$5M-20.0%

Cal-Maine FoodsCALM

$2.21M+144%

SPX TechnologiesSPXC

$0-100%

Royalty PharmaRPRX

-$20.17M+56.0%

Other financials

Income statement

See full

Revenue$8.3M+96.3%

Operating income-$57.5M+8.2%

Net income-$43.2M+5.4%

EPS (diluted)-$0.14+6.7%

Balance sheet

See full

Cash & equivalents$102.1M-44.6%

Total debt$140.2M+107%

Total equity$938.1M-8.3%

Total assets$1.3B-2.8%

Cash flow

See full

Operating cash flow-$33.5M-190%

CapEx$3.8M-64.0%

Free cash flow-$37.4M-68.3%

Valuation

See full

Market cap$1.84B+59.2%

Enterprise value$1.88B+100.0%

P/S23.3×-26.8×

Profitability

See full

Operating margin-267.6%-120pp

Net margin-181.7%-77.9pp

FCF margin-238.9%-90.9pp

Returns & leverage

See full

Return on equity-14.7%-0.8pp

Debt / equity0.1×+0.1×

Current ratio14.1×+3.9×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount.

The official record: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbCellera Biologics Inc.'s unrealized gain on equity investment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AbCellera Biologics Inc.'s unrealized gain on equity investment?: AbCellera Biologics Inc. (ABCL) reported unrealized gain on equity investment of $50K in Q4 2025.
How has AbCellera Biologics Inc.'s unrealized gain on equity investment changed year-over-year?: AbCellera Biologics Inc.'s unrealized gain on equity investment decreased by 98.8% year-over-year, from $4.15M to $50K.
What is the long-term trend for AbCellera Biologics Inc.'s unrealized gain on equity investment?: Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s unrealized gain on equity investment has grown at a -66.7% compound annual growth rate (CAGR), from $1.8M to $200K.